Back

Predictors of mitral valve hemodynamics after mitral valve repair for degenerative mitral regurgitation: a subanalysis of the CAMRA randomized trial

26 August 2022 (13:15 - 14:00)
Organised by:
Congress Presentation Part of: Mitral valve interventions / TEER Mitral Valve Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Rawan Rumman

St. Michael's Hospital, Toronto (Canada)

6 More presentations in this session

Presentation thumbnail
Validation of expert criteria proposed by the "German Cardiac Society" for predicting procedural complexity in transcatheter edge-to-edge mitral valve repair
Doctor C. Metze (Cologne, DE)
Abstract Slides
Presentation thumbnail
Staging heart failure patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair
Mr L. Stolz (Munich, DE)
Abstract Slides
Presentation thumbnail
5-year outcomes of patients with mitral structural valve deterioration treated with transcatheter valve in valve implantation
Doctor N. Schamroth Pravda (Petah Tikva, IL)
Abstract Slides
Presentation thumbnail
Transcatheter mitral-valve repair for functional mitral regurgitation data from the real-life in comparison with landmark randomized trials
Doctor R. Kaddoura (Doha, QA)
Abstract Slides
Presentation thumbnail
Effect of frailty on in-hospital outcomes after transcatheter mitral valve repair
Doctor J. Lopez (Aventura, US)
Abstract Slides

Access the full session

Session thumbnail
Mitral valve interventions / TEER

The Event

Event poster

ESC Congress 2022

26 August 2022 13:15 CET
You may be interested in
thumbnail
Congress Session
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Presentation
Primary mitral regurgitation and mitral stenosis: evaluation and treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources